Multiple meningiomas arising during long-term therapy with the progesterone agonist megestrol acetate. Case report.

Article Details

Citation

Copy to clipboard

Gruber T, Dare AO, Balos LL, Lele S, Fenstermaker RA

Multiple meningiomas arising during long-term therapy with the progesterone agonist megestrol acetate. Case report.

J Neurosurg. 2004 Feb;100(2):328-31.

PubMed ID

15086241 [ View in PubMed

]

Abstract

In this report the authors describe a woman with low-grade endometrial stromal sarcoma who was treated with total abdominal hysterectomy and bilateral salpingo-oophorectomy. After receiving megestrol acetate continuously for 19 years for chronic hormone suppression, she began to experience progressive dementia. Magnetic resonance imaging revealed 11 separate intracranial meningiomas of various sizes. The largest lesions were treated with staged angiographically guided embolization and excision. Despite discontinuation of megestrol acetate, the remaining smaller lesions grew slightly in size, requiring further treatment with a combination of excision and gamma knife stereotactic surgery. All of the excised tumors showed positive staining for progesterone receptors on immunohistochemical examination. Prolonged therapy with megestrol acetate could promote the growth of benign intracranial meningiomas in some patients.

DrugBank Data that Cites this Article

Drug Targets

Drug	Target	Kind	Organism	Pharmacological Action	Actions
Megestrol acetate	Progesterone receptor	Protein	Humans	Yes	Agonist	Details